Webinar Recap: Digital Therapeutics: Optimizing Your Commercial Strategy

 

Digital therapeutics (DTx) are becoming a valuable component of pharma’s development and commercialization strategies. When done right, they can help improve drug efficacy and provide valuable support for people with complex, chronic conditions.

Biofourmis, a data analytics company, brought together digital health experts from Roche, Capgemini, and its own subject matter expert to discuss how pharma can maximize the value of DTx. Here’s a brief run-down of what they discussed.

...